BAMF
LEGN icon

BI Asset Management Fondsmaeglerselskab’s Legend Biotech LEGN Stock Holding History

BI Asset Management Fondsmaeglerselskab’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,318
Closed -$186K – 693
2024
Q1 		$186K Sell
3,318
-15,270
-82% -$921K ﹤0.01% 634
2023
Q4 		$1.12M Buy
18,588
+1,878
+11% +$119K 0.02% 381
2023
Q3 		$1.12M Buy
+16,710
New +$1.16M 0.03% 347

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

BI Asset Management Fondsmaeglerselskab's LEGN Position: Q2 2024 in Review

BI Asset Management Fondsmaeglerselskab sold out of Legend Biotech (LEGN) in Q2 2024, closing a stake of 3,318 shares — an estimated $186K sold.

BI Asset Management Fondsmaeglerselskab first reported a position in LEGN in Q3 2023 and held it in 3 quarters. The position peaked at $1.12M in Q3 2023. 181 funds tracked by Wall St. Rank hold LEGN as of Q2 2024.

  • BI Asset Management Fondsmaeglerselskab reported no remaining Legend Biotech position as of Q2 2024 after selling out during the quarter.
  • BI Asset Management Fondsmaeglerselskab sold 3,318 Legend Biotech shares in Q2 2024, an estimated $186K.
  • BI Asset Management Fondsmaeglerselskab first reported a position in Legend Biotech in Q3 2023 and held it in 3 quarters.
  • BI Asset Management Fondsmaeglerselskab's Legend Biotech position peaked at $1.12M in Q3 2023.
  • 181 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2024.

Based on BI Asset Management Fondsmaeglerselskab's 13F filing for Q2 2024, filed 14 Aug 2024.